Animal Pharmaceuticals Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 28.01 Billion
CAGR (2026-2031)	6.01%
Fastest Growing Segment	Vaccine
Largest Market	North America
Market Size (2031)	USD 39.76 Billion

Market Overview

The Global Animal Pharmaceuticals Market will grow from USD 28.01 Billion in 2025 to USD 39.76 Billion by 2031 at a 6.01% CAGR. The Global Animal Pharmaceuticals Market encompasses the research, development, and commercialization of veterinary drugs, vaccines, and medicated feed additives intended for the prevention and treatment of diseases in livestock and companion animals. The sector is primarily propelled by the escalating global necessity for food security, which demands efficient livestock production, alongside the heightened prevalence of zoonotic pathogens that require robust disease management protocols. Additionally, the deepening emotional bond between owners and their companion animals significantly drives expenditure on veterinary healthcare. According to Animal Medicines Australia, in 2025, the estimated pet population in the country reached 31.6 million, with 73% of households owning a pet, illustrating the substantial and growing customer base that supports the industry's trajectory.

However, a significant challenge impeding broader market expansion is the intensifying regulatory scrutiny regarding antimicrobial resistance. Governments and international health organizations are enforcing increasingly stringent controls on the administration of antibiotics in livestock to safeguard public health. This rigid regulatory environment forces pharmaceutical companies to navigate complex compliance landscapes and restricts the sales volume of established antimicrobial portfolios. Consequently, manufacturers must incur substantial costs to reformulate products and invest in alternative therapeutic solutions, which creates a barrier to the seamless commercial growth of the global market.

Key Market Drivers

The intensification of livestock production to meet the increasing global demand for animal-derived protein acts as a fundamental driver for the industry. As producers shift towards high-density industrial farming to maximize yield, the susceptibility of herds to infectious diseases rises, necessitating robust schedules of vaccines, parasiticides, and medicated feed additives. This reliance on pharmaceutical interventions is critical not only for maintaining herd health but also for ensuring food safety standards in international trade. According to the Food and Agriculture Organization, June 2024, in the 'Food Outlook - Biannual Report on Global Food Markets', world meat production is forecast to expand to 371 million tonnes in 2024. This production volume underscores the immense scale of biological assets requiring pharmaceutical protection to prevent economic losses from outbreaks.

Simultaneously, the market is being reshaped by the escalating trend of pet humanization and the subsequent rise in healthcare expenditure. Owners increasingly view companion animals as family members, prompting a willingness to invest in advanced therapies for chronic conditions, such as oncology and dermatology, rather than basic care. This shift is further supported by the growing adoption of pet insurance, which mitigates the financial burden of expensive veterinary treatments. According to the North American Pet Health Insurance Association, May 2024, in the 'State of the Industry Report 2024', the total premium volume for pet insurance in the U.S. reached $3.9 billion in 2023. Reflecting the broader financial health of the sector driven by these dual engines, according to Zoetis Inc., in 2024, the company reported a full-year revenue of $8.5 billion for the fiscal year 2023.

Download Free Sample Report

Key Market Challenges

The intensifying regulatory scrutiny regarding antimicrobial resistance presents a substantial impediment to the expansion of the Global Animal Pharmaceuticals Market. Governments and international health authorities are enforcing strict controls that directly limit the commercial viability of antibiotic portfolios, which have historically been a reliable revenue stream for veterinary pharmaceutical companies. This rigid compliance landscape forces manufacturers to incur significant expenditures on reformulating existing products to remove growth-promotion claims and meeting elevated surveillance requirements, thereby diverting capital that could otherwise support broader market expansion.

The tangible impact of these restrictions is a marked contraction in the volume of antimicrobial agents sold globally, as companies are compelled to reduce their reliance on these therapeutic classes. According to HealthforAnimals, in 2024, the association reported that global sales of antibiotics by its members declined by 29.9% between 2015 and 2022, highlighting the structural reduction in this market segment. This regulatory pressure effectively caps the growth potential of therapeutic drug categories, compelling the industry to undergo a costly and complex transition toward preventative healthcare solutions rather than enjoying seamless commercial growth from established product lines.

Key Market Trends

The mainstream commercialization of species-specific monoclonal antibodies (mAbs) is fundamentally altering the therapeutic landscape by providing targeted, low-toxicity options for chronic conditions such as osteoarthritis and dermatology. Unlike traditional chemical drugs, these biologics offer precise mechanisms of action that minimize systemic side effects, prompting manufacturers to heavily invest in specialized infrastructure to meet surging clinical demand. This structural shift toward biological production capacity is exemplified by major supply-side commitments; according to Elanco Animal Health Incorporated, August 2024, in the press release 'Elanco Invests $130 Million in Expansion to Boost Monoclonal Antibody Production', the company announced a $130 million investment to expand its biologics manufacturing facility in Kansas specifically to support the growth of its monoclonal antibody platform. This capital allocation highlights the industry's decisive pivot from broad-spectrum pharmaceuticals toward advanced, species-specific biological innovations.

Concurrently, the convergence of veterinary telehealth and digital pharmacy channels is reshaping how animal health products are prescribed, purchased, and delivered to end-users. This trend is characterized by the integration of virtual care platforms with automated e-commerce fulfillment, creating a seamless loop that enhances medication compliance and solidifies recurring revenue streams for digital incumbents. The market dominance of these automated digital procurement models is evident in recent financial performance metrics; according to Chewy, Inc., March 2024, in the 'Fiscal Year 2023 Letter to Shareholders', Autoship customer sales reached $8.49 billion for the fiscal year 2023, representing over 76% of total net sales. This substantial volume indicates a permanent structural migration of purchasing behavior away from sporadic clinic-based sales toward convenient, subscription-based digital health ecosystems.

Segmental Insights

The vaccines segment represents the fastest-growing category in the global animal pharmaceuticals market, primarily due to an industry-wide transition toward preventive healthcare. Rising occurrences of zoonotic diseases and heightened focus on food security have necessitated robust immunization programs among livestock producers. Additionally, guidelines from the World Organisation for Animal Health advocate for vaccination to control outbreaks and reduce reliance on antibiotics. This strategic emphasis on preventing infection, rather than treating established conditions, supports the accelerated demand for veterinary vaccines across companion and production animal sectors.

Regional Insights

North America holds the leading position in the global animal pharmaceuticals market due to widespread pet ownership and consistent expenditure on veterinary services. The region benefits from established medical infrastructure that supports preventative care for both companion animals and livestock. This market strength is supported by the presence of major manufacturers and a clear regulatory framework enforced by the U.S. Food and Drug Administration (FDA). These guidelines ensure product safety and streamline the approval of new treatments. Furthermore, the strong demand for animal-derived food products drives the need for effective disease management in agriculture.

Recent Developments

In December 2024, the world's largest animal health company announced the launch of a new artificial intelligence-powered diagnostic device for veterinary hematology. The cartridge-based, screenless analyzer was designed to deliver laboratory-quality complete blood count results at the point of care within minutes. By utilizing advanced imaging and microfluidic technology, the device aims to streamline veterinary clinic workflows and improve diagnostic accuracy for companion animals. The product rollout was scheduled to commence in early 2025, targeting major markets including the United States and the United Kingdom, reflecting the company's continuous investment in digital and diagnostic innovations.
In September 2024, a multinational animal health corporation received approval from the U.S. Food and Drug Administration for a novel once-daily oral medication designed to treat allergic and atopic dermatitis in dogs. The newly approved drug, a JAK inhibitor, was developed to control pruritus and skin lesions, offering a safe and effective alternative to existing treatments. This regulatory success marked the company's entry into the high-value canine dermatology segment, with the product demonstrating rapid onset of action and sustained efficacy in clinical trials, thereby providing veterinarians with a differentiated tool to manage chronic allergic conditions.
In July 2024, a leading global animal health company completed the acquisition of the aquaculture business of another industry major for approximately $1.3 billion in cash. This strategic expansion integrated a diverse portfolio of aquatic medicines, vaccines, and nutritional products into the acquirer's existing offerings, positioning it as a dominant player in both warm and cold-water fish health markets. The deal included the transfer of key manufacturing and research facilities in Canada, Vietnam, and Chile, reinforcing the company's commitment to technological advancement and sustainability in the aquaculture sector to meet growing global protein demand.
In July 2024, a specialist veterinary pharmaceuticals business agreed to acquire a biotechnology firm focused on protein-based therapeutics for companion animals. The transaction, valued at up to $520 million, aimed to bolster the company's innovation pipeline with species-specific monoclonal antibodies for chronic diseases in dogs and cats. This strategic move was intended to secure entry into the rapidly growing market for long-acting veterinary therapeutics, complementing the acquirer's existing portfolio of specialty products. The acquisition underscored the industry's shift towards advanced biotechnology solutions, promising to deliver novel treatment options that enhance the quality of life for pets.

Key Market Players

Zoetis Inc.
Elanco Animal Health Incorporated
C.H. Boehringer Sohn AG & Co. KG
Merck & Co., Inc
Ceva Santé Animale S.A.,
Vetoquinol S.A.
Bayer AG
Virbac SA
Phibro Animal Health Corporation
Dechra Pharmaceuticals plc

By Product Type	By Animal Type	By Route of Administration	By Type of Infection	By End User	By Distribution Channel	By Region
Drugs Vaccine Medicated Feed	Companion Animal Livestock Animal	Oral Parenteral Topical	Viral Bacterial Parasitic Others	Veterinary Hospitals Veterinary Clinics Point of care/In-house testing Others	Veterinary Hospitals Pharmacies and Drug stores E-commerce	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Animal Pharmaceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Animal Pharmaceuticals Market, By Product Type:

Drugs
Vaccine
Medicated Feed

Animal Pharmaceuticals Market, By Animal Type:

Companion Animal
Livestock Animal

Animal Pharmaceuticals Market, By Route of Administration:

Oral
Parenteral
Topical

Animal Pharmaceuticals Market, By Type of Infection:

Viral
Bacterial
Parasitic
Others

Animal Pharmaceuticals Market, By End User:

Veterinary Hospitals
Veterinary Clinics
Point of care/In-house testing
Others

Animal Pharmaceuticals Market, By Distribution Channel:

Veterinary Hospitals
Pharmacies and Drug stores
E-commerce

Animal Pharmaceuticals Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Animal Pharmaceuticals Market.

Available Customizations:

Global Animal Pharmaceuticals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Animal Pharmaceuticals Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Animal Pharmaceuticals Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product Type (Drugs, Vaccine, Medicated Feed)

5.2.2. By Animal Type (Companion Animal, Livestock Animal)

5.2.3. By Route of Administration (Oral, Parenteral, Topical)

5.2.4. By Type of Infection (Viral, Bacterial, Parasitic, Others)

5.2.5. By End User (Veterinary Hospitals, Veterinary Clinics, Point of care/In-house testing, Others)

5.2.6. By Distribution Channel (Veterinary Hospitals, Pharmacies and Drug stores, E-commerce)

5.2.7. By Region

5.2.8. By Company (2025)

5.3. Market Map

6. North America Animal Pharmaceuticals Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product Type

6.2.2. By Animal Type

6.2.3. By Route of Administration

6.2.4. By Type of Infection

6.2.5. By End User

6.2.6. By Distribution Channel

6.2.7. By Country

6.3. North America: Country Analysis

6.3.1. United States Animal Pharmaceuticals Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product Type

6.3.1.2.2. By Animal Type

6.3.1.2.3. By Route of Administration

6.3.1.2.4. By Type of Infection

6.3.1.2.5. By End User

6.3.1.2.6. By Distribution Channel

6.3.2. Canada Animal Pharmaceuticals Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product Type

6.3.2.2.2. By Animal Type

6.3.2.2.3. By Route of Administration

6.3.2.2.4. By Type of Infection

6.3.2.2.5. By End User

6.3.2.2.6. By Distribution Channel

6.3.3. Mexico Animal Pharmaceuticals Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product Type

6.3.3.2.2. By Animal Type

6.3.3.2.3. By Route of Administration

6.3.3.2.4. By Type of Infection

6.3.3.2.5. By End User

6.3.3.2.6. By Distribution Channel

7. Europe Animal Pharmaceuticals Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product Type

7.2.2. By Animal Type

7.2.3. By Route of Administration

7.2.4. By Type of Infection

7.2.5. By End User

7.2.6. By Distribution Channel

7.2.7. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Animal Pharmaceuticals Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product Type

7.3.1.2.2. By Animal Type

7.3.1.2.3. By Route of Administration

7.3.1.2.4. By Type of Infection

7.3.1.2.5. By End User

7.3.1.2.6. By Distribution Channel

7.3.2. France Animal Pharmaceuticals Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product Type

7.3.2.2.2. By Animal Type

7.3.2.2.3. By Route of Administration

7.3.2.2.4. By Type of Infection

7.3.2.2.5. By End User

7.3.2.2.6. By Distribution Channel

7.3.3. United Kingdom Animal Pharmaceuticals Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product Type

7.3.3.2.2. By Animal Type

7.3.3.2.3. By Route of Administration

7.3.3.2.4. By Type of Infection

7.3.3.2.5. By End User

7.3.3.2.6. By Distribution Channel

7.3.4. Italy Animal Pharmaceuticals Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product Type

7.3.4.2.2. By Animal Type

7.3.4.2.3. By Route of Administration

7.3.4.2.4. By Type of Infection

7.3.4.2.5. By End User

7.3.4.2.6. By Distribution Channel

7.3.5. Spain Animal Pharmaceuticals Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product Type

7.3.5.2.2. By Animal Type

7.3.5.2.3. By Route of Administration

7.3.5.2.4. By Type of Infection

7.3.5.2.5. By End User

7.3.5.2.6. By Distribution Channel

8. Asia Pacific Animal Pharmaceuticals Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product Type

8.2.2. By Animal Type

8.2.3. By Route of Administration

8.2.4. By Type of Infection

8.2.5. By End User

8.2.6. By Distribution Channel

8.2.7. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Animal Pharmaceuticals Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product Type

8.3.1.2.2. By Animal Type

8.3.1.2.3. By Route of Administration

8.3.1.2.4. By Type of Infection

8.3.1.2.5. By End User

8.3.1.2.6. By Distribution Channel

8.3.2. India Animal Pharmaceuticals Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product Type

8.3.2.2.2. By Animal Type

8.3.2.2.3. By Route of Administration

8.3.2.2.4. By Type of Infection

8.3.2.2.5. By End User

8.3.2.2.6. By Distribution Channel

8.3.3. Japan Animal Pharmaceuticals Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product Type

8.3.3.2.2. By Animal Type

8.3.3.2.3. By Route of Administration

8.3.3.2.4. By Type of Infection

8.3.3.2.5. By End User

8.3.3.2.6. By Distribution Channel

8.3.4. South Korea Animal Pharmaceuticals Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product Type

8.3.4.2.2. By Animal Type

8.3.4.2.3. By Route of Administration

8.3.4.2.4. By Type of Infection

8.3.4.2.5. By End User

8.3.4.2.6. By Distribution Channel

8.3.5. Australia Animal Pharmaceuticals Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product Type

8.3.5.2.2. By Animal Type

8.3.5.2.3. By Route of Administration

8.3.5.2.4. By Type of Infection

8.3.5.2.5. By End User

8.3.5.2.6. By Distribution Channel

9. Middle East & Africa Animal Pharmaceuticals Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product Type

9.2.2. By Animal Type

9.2.3. By Route of Administration

9.2.4. By Type of Infection

9.2.5. By End User

9.2.6. By Distribution Channel

9.2.7. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Animal Pharmaceuticals Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product Type

9.3.1.2.2. By Animal Type

9.3.1.2.3. By Route of Administration

9.3.1.2.4. By Type of Infection

9.3.1.2.5. By End User

9.3.1.2.6. By Distribution Channel

9.3.2. UAE Animal Pharmaceuticals Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product Type

9.3.2.2.2. By Animal Type

9.3.2.2.3. By Route of Administration

9.3.2.2.4. By Type of Infection

9.3.2.2.5. By End User

9.3.2.2.6. By Distribution Channel

9.3.3. South Africa Animal Pharmaceuticals Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product Type

9.3.3.2.2. By Animal Type

9.3.3.2.3. By Route of Administration

9.3.3.2.4. By Type of Infection

9.3.3.2.5. By End User

9.3.3.2.6. By Distribution Channel

10. South America Animal Pharmaceuticals Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product Type

10.2.2. By Animal Type

10.2.3. By Route of Administration

10.2.4. By Type of Infection

10.2.5. By End User

10.2.6. By Distribution Channel

10.2.7. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Animal Pharmaceuticals Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product Type

10.3.1.2.2. By Animal Type

10.3.1.2.3. By Route of Administration

10.3.1.2.4. By Type of Infection

10.3.1.2.5. By End User

10.3.1.2.6. By Distribution Channel

10.3.2. Colombia Animal Pharmaceuticals Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product Type

10.3.2.2.2. By Animal Type

10.3.2.2.3. By Route of Administration

10.3.2.2.4. By Type of Infection

10.3.2.2.5. By End User

10.3.2.2.6. By Distribution Channel

10.3.3. Argentina Animal Pharmaceuticals Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product Type

10.3.3.2.2. By Animal Type

10.3.3.2.3. By Route of Administration

10.3.3.2.4. By Type of Infection

10.3.3.2.5. By End User

10.3.3.2.6. By Distribution Channel

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Animal Pharmaceuticals Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Zoetis Inc.

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. Elanco Animal Health Incorporated

15.3. C.H. Boehringer Sohn AG & Co. KG

15.4. Merck & Co., Inc

15.5. Ceva Santé Animale S.A.,

15.6. Vetoquinol S.A.

15.7. Bayer AG

15.8. Virbac SA

15.9. Phibro Animal Health Corporation

15.10. Dechra Pharmaceuticals plc

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

List of Figures

Figure 1: Global Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 2: Global Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 3: Global Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 4: Global Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 5: Global Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 6: Global Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 7: Global Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 8: Global Animal Pharmaceuticals Market, By Region, By Value, 2016-2026F

Figure 9: Global Animal Pharmaceuticals Market, Market Map, By Value, 2016-2026F

Figure 10: North America Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 11: North America Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 12: North America Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 13: North America Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 14: North America Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 15: North America Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 16: North America Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 17: North America Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F

Figure 18: United States Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 19: United States Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 20: United States Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 21: United States Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 22: United States Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 23: United States Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 24: United States Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 25: Canada Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 26: Canada Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 27: Canada Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 28: Canada Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 29: Canada Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 30: Canada Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 31: Canada Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 32: Mexico Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 33: Mexico Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 34: Mexico Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 35: Mexico Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 36: Mexico Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 37: Mexico Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 38: Mexico Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 39: Europe Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 40: Europe Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 41: Europe Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 42: Europe Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 43: Europe Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 44: Europe Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 45: Europe Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 46: Europe Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F

Figure 47: Germany Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 48: Germany Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 49: Germany Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 50: Germany Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 51: Germany Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 52: Germany Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 53: Germany Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 54: United Kingdom Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 55: United Kingdom Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 56: United Kingdom Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 57: United Kingdom Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 58: United Kingdom Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 59: United Kingdom Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 60: United Kingdom Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 61: France Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 62: France Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 63: France Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 64: France Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 65: France Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 66: France Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 67: France Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 68: Italy Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 69: Italy Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 70: Italy Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 71: Italy Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 72: Italy Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 73: Italy Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 74: Italy Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 75: Spain Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 76: Spain Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 77: Spain Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 78: Spain Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 79: Spain Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 80: Spain Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 81: Spain Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 82: Asia-Pacific Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 83: Asia-Pacific Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 84: Asia-Pacific Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 85: Asia-Pacific Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 86: Asia-Pacific Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 87: Asia-Pacific Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 88: Asia-Pacific Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 89: Asia-Pacific Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F

Figure 90: Australia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 91: Australia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 92: Australia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 93: Australia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 94: Australia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 95: Australia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 96: Australia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 97: Japan Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 98: Japan Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 99: Japan Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 100: Japan Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 101: Japan Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 102: Japan Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 103: Japan Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 104: China Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 105: China Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 106: China Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 107: China Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 108: China Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 109: China Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 110: China Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 111: India Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 112: India Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 113: India Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 114: India Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 115: India Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 116: India Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 117: India Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 118: South Korea Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 119: South Korea Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 120: South Korea Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 121: South Korea Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 122: South Korea Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 123: South Korea Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 124: South Korea Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 125: South America Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 126: South America Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 127: South America Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 128: South America Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 129: South America Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 130: South America Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 131: South America Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 132: South America Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F

Figure 133: Argentina Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 134: Argentina Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 135: Argentina Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 136: Argentina Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 137: Argentina Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 138: Argentina Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 139: Argentina Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 140: Brazil Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 141: Brazil Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 142: Brazil Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 143: Brazil Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 144: Brazil Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 145: Brazil Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 146: Brazil Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 147: Colombia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 148: Colombia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 149: Colombia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 150: Colombia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 151: Colombia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 152: Colombia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 153: Colombia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 154: Middle East and Africa Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 155: Middle East and Africa Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 156: Middle East and Africa Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 157: Middle East and Africa Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 158: Middle East and Africa Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 159: Middle East and Africa Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 160: Middle East and Africa Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 161: Middle East and Africa Animal Pharmaceuticals Market, By Country, By Value, 2016-2026F

Figure 162: South Africa Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 163: South Africa Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 164: South Africa Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 165: South Africa Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 166: South Africa Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 167: South Africa Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 168: South Africa Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 169: Saudi Arabia Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 170: Saudi Arabia Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 171: Saudi Arabia Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 172: Saudi Arabia Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 173: Saudi Arabia Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 174: Saudi Arabia Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 175: Saudi Arabia Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Figure 176: UAE Animal Pharmaceuticals Market Size, By Value (USD Million), 2016-2026F

Figure 177: UAE Animal Pharmaceuticals Market Share, By Product Type, By Value, 2016-2026F

Figure 178: UAE Animal Pharmaceuticals Market Share, By Animal Type, By Value, 2016-2026F

Figure 179: UAE Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2016-2026F

Figure 180: UAE Animal Pharmaceuticals Market Share, By Type of Infection, By Value, 2016-2026F

Figure 181: UAE Animal Pharmaceuticals Market Share, By End User, By Value, 2016-2026F

Figure 182: UAE Animal Pharmaceuticals Market Share, By Distribution Channel, By Value, 2016-2026F

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Animal Pharmaceuticals Market in 2025?

Which is the dominating region in the Global Animal Pharmaceuticals Market?

Which is the fastest growing segment in the Global Animal Pharmaceuticals Market?

What is the expected growth rate of the Global Animal Pharmaceuticals Market?